Clinical Trial Update: Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials [EARLY_Phase 1]

View source ↗

Summary

Early-phase (Phase 1) exploratory trial evaluating recombinant human serum albumin for Alzheimer's disease, sponsored by Protgen Ltd. The study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Recombinant Human Serum Albumin (recombinant human serum albumin)

Snippet

Sponsor: Protgen Ltd | Conditions: Alzheimer's Disease (AD) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING